Rigel Pharma (RIGL) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $1.10 -2.65%
Revenue Growth %: +21.1%
Financial Fact:
Interest income: 110K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: +21.1%
Financial Fact:
Interest income: 110K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) reported Q1 EPS of ($0.40), $0.04 worse than the analyst estimate of ($0.36).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- L3Harris Technologies (LHX) Tops Q1 EPS by 15c; raises guidance
- SkyWest (SKYW) Tops Q1 EPS by 28c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
